These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19342956)

  • 1. Costimulation blockade in rheumatic diseases: where we are?
    Goëb V; Buch MH; Vital EM; Emery P
    Curr Opin Rheumatol; 2009 May; 21(3):244-50. PubMed ID: 19342956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy.
    Goldzweig O; Hashkes PJ
    Drug Des Devel Ther; 2011 Jan; 5():61-70. PubMed ID: 21340039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation].
    Dejaco C; Duftner C; Wipfler E; Schirmer M
    Wien Med Wochenschr; 2009; 159(3-4):70-5. PubMed ID: 19247593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
    Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-Pérez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalhães C; Sztajnbok F; Goldenstein-Schainberg C; Scheinberg M; Penades IC; Fischbach M; Orozco J; Hashkes PJ; Hom C; Jung L; Lepore L; Oliveira S; Wallace CA; Sigal LH; Block AJ; Covucci A; Martini A; Giannini EH; ;
    Lancet; 2008 Aug; 372(9636):383-91. PubMed ID: 18632147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
    Sherrer Y
    Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abatacept: a review of its use in the management of rheumatoid arthritis.
    Keating GM
    Drugs; 2013 Jul; 73(10):1095-119. PubMed ID: 23794171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis.
    Ostör AJ
    Clin Rheumatol; 2008 Nov; 27(11):1343-53. PubMed ID: 18670735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of abatacept in rheumatoid arthritis.
    von Kempis J; Dudler J; Hasler P; Kyburz D; Tyndall A; Zufferey P; Villiger PM
    Swiss Med Wkly; 2012; 142():w13581. PubMed ID: 22581564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CTLA4-Ig (abatacept)].
    Harigai M
    Nihon Rinsho; 2007 Jul; 65(7):1231-7. PubMed ID: 17642237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abatacept.
    Vital EM; Emery P
    Drugs Today (Barc); 2006 Feb; 42(2):87-93. PubMed ID: 16541185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of abatacept in the management of rheumatoid arthritis.
    Nogid A; Pham DQ
    Clin Ther; 2006 Nov; 28(11):1764-78. PubMed ID: 17212998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abatacept: a novel treatment for rheumatoid arthritis.
    Lundquist LM
    Expert Opin Pharmacother; 2007 Oct; 8(14):2371-9. PubMed ID: 17927490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.
    Laganà B; Vinciguerra M; D'Amelio R
    Clin Drug Investig; 2009; 29(3):185-202. PubMed ID: 19243211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics.
    Mijnheer G; Prakken BJ; van Wijk F
    Curr Opin Rheumatol; 2013 Mar; 25(2):260-7. PubMed ID: 23274520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abatacept in the treatment of rheumatoid arthritis.
    Todd DJ; Costenbader KH; Weinblatt ME
    Int J Clin Pract; 2007 Mar; 61(3):494-500. PubMed ID: 17313619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid arthritis.
    Shergy WJ
    Semin Arthritis Rheum; 2009 Jun; 38(6):434-43. PubMed ID: 18538830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abatacept: a biologic immune modulator for rheumatoid arthritis.
    Papagoras C; Drosos AA
    Expert Opin Biol Ther; 2011 Aug; 11(8):1113-29. PubMed ID: 21649536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis].
    Harigai M
    Clin Calcium; 2007 Apr; 17(4):577-84. PubMed ID: 17404488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective co-stimulation blockade. CTLA4-Ig (Abatacept)].
    Alten R; Märker-Hermann E
    Z Rheumatol; 2010 Sep; 69(7):601-7. PubMed ID: 20703487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.
    Weinblatt M; Combe B; Covucci A; Aranda R; Becker JC; Keystone E
    Arthritis Rheum; 2006 Sep; 54(9):2807-16. PubMed ID: 16947384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.